Our Pipeline

Best-In-Class Cancer Therapuetics

Sutro’s Robust Pipeline of Product Candidates Demonstrates our Innovative Processes and Designed Intentionally to Expand Patient Benefit in Areas of High Unmet Need


Sutro Biopharma is a clinical stage company working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies, and cytokine-based therapeutics targeting immuno-oncology and autoimmune pathways.

Our Pipeline of Product Candidates and Programs, all based on our proprietary XpressCF® and XpressCF+® platforms, are summarized in the chart below:

Sutro's Pipeline June 2023